LSV Asset Management
INDV icon

LSV Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

LSV Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42M Buy
1,024,724
+650,990
+174% +$23.6M 0.08% 266
2026
Q1 		$11.4M Buy
373,734
+82,600
+28% +$2.73M 0.02% 384
2025
Q4 		$10.4M Buy
291,134
+270,834
+1,334% +$8.27M 0.02% 382
2025
Q3 		$489K Buy
+20,300
New +$425K ﹤0.01% 702

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management's INDV Position: Q2 2026 in Review

LSV Asset Management increased its Indivior Pharmaceuticals (INDV) stake by 174% in Q2 2026, buying an estimated $23.6M and bringing the position to 1,024,724 shares worth $42M. The position accounts for 0.08% of the portfolio, ranked #266.

LSV Asset Management first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • LSV Asset Management held 1,024,724 shares of Indivior Pharmaceuticals worth $42M as of Q2 2026.
  • LSV Asset Management bought 650,990 Indivior Pharmaceuticals shares in Q2 2026, an estimated $23.6M.
  • Indivior Pharmaceuticals made up 0.08% of LSV Asset Management's portfolio in Q2 2026, its #266 holding.
  • LSV Asset Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.